BioSpace News Archive

Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced full enrollment of its pivotal trial evaluating the bioequivalence (BE) of ACER-001 compared to BUPHENYL® (sodium phenylbutyrate)

Monopar Therapeutics today announced the issuance of a U.S. patent (US 10,450,340) covering compositions of matter for a novel family of camsirubicin analogs.

Veteran life science investor and industry analyst brings robust financial acumen and life science sector expertise to next-generation liquid biopsy company

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the submission of the supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for DEXTENZA® (dexamethasone ophthalmic ins

Venus Concept Inc. (“Venus Concept” or the “Company”) (Nasdaq: VERO), a global medical aesthetic technology leader, today announced the pricing of its public offering of 11,250,000 shares of its common stock and warrants to purchase 5,625,000 shares of common stock at a combined offering price to the public of $2.00 per share and accompanying warrant. The warrants have an exercise price of $2.50 per share of common stock, are exercisable immediately,

Global health service company Cigna Corporation (NYSE:CI) today announced that David Cordani , president and chief executive officer, will present at the 39 th Annual J.P. Morgan Healthcare Conference, Jan. 12, 2021 , through a virtual webcast.

The development and authorization of a COVID-19 vaccine is a critical scientific milestone in our efforts to combat this pandemic. Abbott released findings from a survey conducted by The Harris Poll, showing that Americans see testing as an essential partner to these new vaccines.

Application is for Patients With Previously Treated Non-Small Cell Lung Cancer (NSCLC) With the KRAS G12C Mutation EU Application Follows Sotorasib New Drug Application Submission to U.S. FDA Announced Last Week

Rapid Medical , a company focused on the development of the first class of responsive, adjustable neurovascular devices, announces the FDA clearance of DRIVEWIRE, a novel guidewire with a steerable distal tip that handles complex anatomical turns with ease. This device is named Columbus outside of the United S

Spectrum Antimicrobials, Inc., announces the launch of Vetricept Skin and Wound Care Cleanser, the first product launch in the Company’s new Animal Health Division.